USSTOCK.TODAY
Market Closed
Log in Sign up

Nektar Therapeutics reports $1.63 loss per share in Q3

Earnings Whispers · ·by G4L

NKTR
NKTR Nektar Therapeutics
$37.27 +0.05%
View chart & analysis →
  1. 1Nektar Therapeutics reported a loss of $1.63 per share in the third quarter.
  2. 2Nektar Therapeutics recorded a 24.5% earnings surprise rate for the third quarter.
  3. 3The CEO described this quarter as 'transformative'.

So what's the key point?

Nektar Therapeutics saw a loss of $1.63 per share in the third quarter. However, the results were 24.5% better than what experts expected, and management says this marks a major change.

Source Earnings Whispers · View original ↗

Related 3-line summaries

Nektar Therapeutics to Announce Q3 Results and Key Updates Nasdaq +1 · Nov 5Trade uncertainty and maritime freight status following US midterm election results FreightWaves · 10m agoLiftoff Mobile Announces Q3 Results and Raises Annual Guidance Earnings Whispers +1 · 10m ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news